Literature DB >> 11765051

Multiple endocrine neoplasia type 1Burin from Mauritius: a novel MEN1 mutation.

C Kong1, S Ellard, C Johnston, N R Farid.   

Abstract

We describe a kindred from Mauritius with an incomplete variant of multiple endocrine neoplasia type 1 (MEN 1Burin). In this family the syndrome is related to a novel MEN 1 gene mutation (deletion of A) at nucleotide 1021 of codon 304 resulting in frame shift and downstream protein truncation at codon 320. Compared to mainstream MEN 1, MEN 1Burin is characterized by a high prevalence of prolactin-secreting pituitary adenomas, late-onset of hyperparathyroidism and rare pancreatic involvement. The family described represents the fifth in the literature with the MEN 1 Burin phenotype; 2 out of the other 4 were related to R460X, Y312X respectively and no mutation within the coding sequence of MEN 1 was found in the other 2. Thus, similar to the classic syndrome, MEN 1Burin phenotype shows poor correlation to MEN 1 genotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11765051     DOI: 10.1007/bf03343931

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Cell cycle regulation of menin expression.

Authors:  H Kaji; L Canaff; D Goltzman; G N Hendy
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

2.  Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland.

Authors:  S E Olufemi; J S Green; P Manickam; S C Guru; S K Agarwal; M B Kester; Q Dong; A L Burns; A M Spiegel; S J Marx; F S Collins; S C Chandrasekharappa
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

3.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

Review 4.  Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.

Authors:  S J Marx; S K Agarwal; M B Kester; C Heppner; Y S Kim; M C Skarulis; L A James; P K Goldsmith; S K Saggar; S Y Park; A M Spiegel; A L Burns; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; M R Emmert-Buck; S C Guru; P Manickam; J Crabtree; M R Erdos; F S Collins; S C Chandrasekharappa
Journal:  Recent Prog Horm Res       Date:  1999

5.  The human HNP36 gene is localized to chromosome 11q13 and produces alternative transcripts that are not mutated in multiple endocrine neoplasia, type 1 (MEN I) syndrome.

Authors:  J B Williams; B Rexer; S Sirripurapu; S John; R Goldstein; J A Phillips; L L Haley; S N Sait; T B Shows; C M Smith; D S Gerhard
Journal:  Genomics       Date:  1997-06-01       Impact factor: 5.736

6.  Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.

Authors:  T N Darling; M C Skarulis; S M Steinberg; S J Marx; A M Spiegel; M Turner
Journal:  Arch Dermatol       Date:  1997-07

7.  Stable overexpression of MEN1 suppresses tumorigenicity of RAS.

Authors:  Y S Kim; A L Burns; P K Goldsmith; C Heppner; S Y Park; S C Chandrasekharappa; F S Collins; A M Spiegel; S J Marx
Journal:  Oncogene       Date:  1999-10-21       Impact factor: 9.867

8.  Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription.

Authors:  S K Agarwal; S C Guru; C Heppner; M R Erdos; R M Collins; S Y Park; S Saggar; S C Chandrasekharappa; F S Collins; A M Spiegel; S J Marx; A L Burns
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

9.  Prolactinomas as part of the multiple endocrine neoplastic syndrome type 1.

Authors:  K S Hershon; W A Kelly; C M Shaw; R Schwartz; E L Bierman
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

10.  Characterization of the MEN1 gene product, menin, by site-specific polyclonal antibodies.

Authors:  Y Ikeo; A Sakurai; K Hashizume
Journal:  Jpn J Cancer Res       Date:  1999-10
View more
  4 in total

1.  Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression.

Authors:  Maria Chiara Zatelli; Federico Tagliati; Mauro Di Ruvo; Emilie Castermans; Luigi Cavazzini; Adrian F Daly; Maria Rosaria Ambrosio; Albert Beckers; Ettore degli Uberti
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 2.  Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations.

Authors:  Chiara Mele; Monica Mencarelli; Marina Caputo; Stefania Mai; Loredana Pagano; Gianluca Aimaretti; Massimo Scacchi; Alberto Falchetti; Paolo Marzullo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-18       Impact factor: 5.555

3.  Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.

Authors:  C Romei; E Pardi; F Cetani; R Elisei
Journal:  J Oncol       Date:  2012-11-08       Impact factor: 4.375

Review 4.  Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.

Authors:  Cornelis J Lips; Koen M Dreijerink; Jo W Höppener
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.